TLR4 and rheumatoid arthritis: The anti-TLR-4 directed actions of carvacrol have been further demonstrated in various tissues such as stimulated cardiomyocytes [71], rheumatoid-arthritis-induced fibroblast-like synoviocytes [72], vascular endothelial cells [73], and brain neuronal cells [74].